Rhumbline Advisers Bridge Bio Pharma, Inc. Transaction History

Rhumbline Advisers

$109 Billion
Q3 2024

A detailed history of Rhumbline Advisers transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Rhumbline Advisers holds 214,113 shares of BBIO stock, worth $6.11 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

214,113

Previous 221,403 3.29%

Holding current value

$6.11 Million

Previous $5.61 Million 2.8%

% of portfolio

0.01%

Previous 0.01%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$23.91 - $31.3 $174,303 - $228,177	-7,290 Reduced 3.29%	214,113 $5.45 Million
Q2 2024 Aug 01, 2024	BUY	$23.0 - $31.04 $832,577 - $1.12 Million	36,199 Added 19.55%	221,403 $5.61 Million
Q1 2024 May 09, 2024	BUY	$27.35 - $40.45 $119,628 - $176,928	4,374 Added 2.42%	185,204 $5.73 Million
Q4 2023 Feb 08, 2024	BUY	$24.02 - $43.89 $25,725 - $47,006	1,071 Added 0.6%	180,830 $7.3 Million
Q3 2023 Nov 09, 2023	BUY	$16.89 - $35.01 $32,496 - $67,359	1,924 Added 1.08%	179,759 $4.74 Million
Q2 2023 Aug 08, 2023	BUY	$13.29 - $18.01 $205,303 - $278,218	15,448 Added 9.51%	177,835 $3.06 Million
Q1 2023 May 11, 2023	BUY	$7.17 - $18.55 $31,892 - $82,510	4,448 Added 2.82%	162,387 $2.69 Million
Q4 2022 Feb 14, 2023	BUY	$6.74 - $11.52 $37,979 - $64,915	5,635 Added 3.7%	157,939 $1.2 Million
Q3 2022 Nov 10, 2022	BUY	$7.94 - $12.36 $89,666 - $139,581	11,293 Added 8.01%	152,304 $1.51 Million
Q2 2022 Aug 11, 2022	BUY	$5.21 - $12.14 $91,279 - $212,692	17,520 Added 14.19%	141,011 $1.28 Million
Q1 2022 May 12, 2022	SELL	$7.34 - $17.16 $28,192 - $65,911	-3,841 Reduced 3.02%	123,491 $1.25 Million
Q4 2021 Feb 10, 2022	SELL	$11.38 - $53.41 $10,230 - $48,015	-899 Reduced 0.7%	127,332 $2.12 Million
Q3 2021 Nov 12, 2021	BUY	$46.87 - $64.24 $82,256 - $112,741	1,755 Added 1.39%	128,231 $6.01 Million
Q2 2021 Aug 05, 2021	BUY	$46.47 - $63.93 $1.07 Million - $1.47 Million	22,957 Added 22.18%	126,476 $7.71 Million
Q1 2021 May 06, 2021	BUY	$55.47 - $72.35 $639,291 - $833,833	11,525 Added 12.53%	103,519 $6.38 Million
Q4 2020 Feb 10, 2021	BUY	$38.38 - $71.11 $22,145 - $41,030	577 Added 0.63%	91,994 $6.54 Million
Q3 2020 Nov 12, 2020	SELL	$27.2 - $42.19 $593,368 - $920,374	-21,815 Reduced 19.27%	91,417 $3.43 Million
Q2 2020 Aug 13, 2020	BUY	$22.22 - $35.69 $177,448 - $285,020	7,986 Added 7.59%	113,232 $3.69 Million
Q1 2020 May 06, 2020	BUY	$16.11 - $36.23 $1.24 Million - $2.79 Million	77,018 Added 272.84%	105,246 $3.05 Million
Q4 2019 Feb 05, 2020	BUY	$17.96 - $46.63 $66,380 - $172,344	3,696 Added 15.07%	28,228 $989,000
Q3 2019 Oct 23, 2019	BUY	$20.13 - $32.38 $493,829 - $794,346	24,532 New	24,532 $527,000

Others Institutions Holding BBIO

# of Institutions

290

Shares Held

170M

Call Options Held

10.4M

Put Options Held

2.37M

View Full List

About BridgeBio Pharma, Inc.

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $4.23B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

More about BBIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Account

Rhumbline Advisers Bridge Bio Pharma, Inc. Transaction History